Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-17-033504
Filing Date
2017-06-22
Accepted
2017-06-22 08:37:46
Documents
20
Period of Report
2017-06-22

Document Format Files

Seq Description Document Type Size
1 6-K v469060_6k.htm 6-K 15807
2 EXHIBIT 99.1 v469060_ex99-1.htm EX-99.1 239483
3 EXHIBIT 99.2 v469060_ex99-2.htm EX-99.2 30331
4 EXHIBIT 99.3 v469060_ex99-3.htm EX-99.3 1785
5 GRAPHIC annex-apg01.jpg GRAPHIC 148578
6 GRAPHIC annex-apg02.jpg GRAPHIC 192453
7 GRAPHIC annex-apg03.jpg GRAPHIC 47102
8 GRAPHIC annex-apg04.jpg GRAPHIC 145248
9 GRAPHIC annex-apg05.jpg GRAPHIC 141013
10 GRAPHIC annex-apg06.jpg GRAPHIC 149930
11 GRAPHIC annex-apg07.jpg GRAPHIC 199591
12 GRAPHIC annex-apg08.jpg GRAPHIC 157581
13 GRAPHIC annex-apg09.jpg GRAPHIC 162151
14 GRAPHIC annex-apg10.jpg GRAPHIC 144983
15 GRAPHIC annex-apg11.jpg GRAPHIC 168127
16 GRAPHIC annex-apg12.jpg GRAPHIC 71271
17 GRAPHIC logo_ex99-1.jpg GRAPHIC 16409
18 GRAPHIC logo_ex99-2.jpg GRAPHIC 16409
19 GRAPHIC pg1_ex99-3.jpg GRAPHIC 96306
20 GRAPHIC pg2_ex99-3.jpg GRAPHIC 65208
  Complete submission text file 0001144204-17-033504.txt   2935542
Mailing Address 5 HACHAROSHET ST. RAANANA L3 4365603
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 6-K | Act: 34 | File No.: 001-36000 | Film No.: 17924081
SIC: 2834 Pharmaceutical Preparations